These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24359082)

  • 41. Methods to Make Homogenous Antibody Drug Conjugates.
    Kline T; Steiner AR; Penta K; Sato AK; Hallam TJ; Yin G
    Pharm Res; 2015 Nov; 32(11):3480-93. PubMed ID: 25511917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats.
    Boswell CA; Mundo EE; Zhang C; Bumbaca D; Valle NR; Kozak KR; Fourie A; Chuh J; Koppada N; Saad O; Gill H; Shen BQ; Rubinfeld B; Tibbitts J; Kaur S; Theil FP; Fielder PJ; Khawli LA; Lin K
    Bioconjug Chem; 2011 Oct; 22(10):1994-2004. PubMed ID: 21913715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of antibody-drug conjugates by mass spectrometry: advances and future trends.
    Huang RY; Chen G
    Drug Discov Today; 2016 May; 21(5):850-5. PubMed ID: 27080148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current approaches for the purification of antibody-drug conjugates.
    Matsuda Y
    J Sep Sci; 2022 Jan; 45(1):27-37. PubMed ID: 34473399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conjugation site characterization of antibody-drug conjugates using electron-transfer/higher-energy collision dissociation (EThcD).
    Song Y; Gao J; Meng Q; Tang F; Wang Y; Zeng Y; Huang W; Shao H; Zhou H
    Anal Chim Acta; 2023 Apr; 1251():340978. PubMed ID: 36925279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of Positional Isomers of Interchain Cysteine Linked Antibody-Drug Conjugates by High-Resolution Mass Spectrometry.
    Li K; Lin ZJ; Shi H; Ma Y
    Anal Chem; 2019 Jul; 91(13):8558-8563. PubMed ID: 31247726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Profiling antibody drug conjugate positional isomers: a system-of-equations approach.
    Le LN; Moore JM; Ouyang J; Chen X; Nguyen MD; Galush WJ
    Anal Chem; 2012 Sep; 84(17):7479-86. PubMed ID: 22913809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioanalytical workflow for novel scaffold protein-drug conjugates: quantitation of total Centyrin protein, conjugated Centyrin and free payload for Centyrin-drug conjugate in plasma and tissue samples using liquid chromatography-tandem mass spectrometry.
    Shi C; Goldberg S; Lin T; Dudkin V; Widdison W; Harris L; Wilhelm S; Jmeian Y; Davis D; O'Neil K; Weng N; Jian W
    Bioanalysis; 2018 Oct; 10(20):1651-1665. PubMed ID: 30372128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis, and in vitro evaluation of dipeptide-based antibody minor groove binder conjugates.
    Jeffrey SC; Torgov MY; Andreyka JB; Boddington L; Cerveny CG; Denny WA; Gordon KA; Gustin D; Haugen J; Kline T; Nguyen MT; Senter PD
    J Med Chem; 2005 Mar; 48(5):1344-58. PubMed ID: 15743178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology.
    Roberts SA; Andrews PA; Blanset D; Flagella KM; Gorovits B; Lynch CM; Martin PL; Kramer-Stickland K; Thibault S; Warner G
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):382-91. PubMed ID: 24012707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody and antibody fragments site-specific conjugation using new Q-tag substrate of bacterial transglutaminase.
    El Alaoui M; Sivado E; Jallas AC; Mebarki L; Dyson MR; Perrez F; Valsesia-Wittmann S; El Alaoui S
    Cell Death Discov; 2024 Feb; 10(1):79. PubMed ID: 38360912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of Native Ion Exchange Mass Spectrometry to Intact and Subunit Analysis of Site-Specific Antibody-Drug Conjugates Produced by AJICAP First Generation Technology.
    Matsuda Y; Kliman M; Mendelsohn BA
    J Am Soc Mass Spectrom; 2020 Jul; ():. PubMed ID: 32608232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development.
    Agarwal P; Bertozzi CR
    Bioconjug Chem; 2015 Feb; 26(2):176-92. PubMed ID: 25494884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insights from native mass spectrometry approaches for top- and middle- level characterization of site-specific antibody-drug conjugates.
    Botzanowski T; Erb S; Hernandez-Alba O; Ehkirch A; Colas O; Wagner-Rousset E; Rabuka D; Beck A; Drake PM; Cianférani S
    MAbs; 2017 Jul; 9(5):801-811. PubMed ID: 28406343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-step high-throughput conjugation platform for the development of antibody-drug conjugates.
    Andris S; Wendeler M; Wang X; Hubbuch J
    J Biotechnol; 2018 Jul; 278():48-55. PubMed ID: 29733878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk-based scientific approach for determination of extractables/leachables from biomanufacturing of antibody-drug conjugates (ADCs).
    Ding W
    Methods Mol Biol; 2013; 1045():303-11. PubMed ID: 23913157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Versatility of microbial transglutaminase.
    Strop P
    Bioconjug Chem; 2014 May; 25(5):855-62. PubMed ID: 24694238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Site-Specific Conjugation of Metal-Chelating Polymers to Anti-Frizzled-2 Antibodies
    Le PJ; Miersch S; Forbes MW; Jarvik N; Ku A; Sidhu SS; Reilly RM; Winnik MA
    Biomacromolecules; 2021 Jun; 22(6):2491-2504. PubMed ID: 33961407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An overview of process development for antibody-drug conjugates produced by chemical conjugation technology.
    Matsuda Y; Mendelsohn BA
    Expert Opin Biol Ther; 2021 Jul; 21(7):963-975. PubMed ID: 33141625
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficient Production of Homogeneous Lysine-Based Antibody Conjugates Using Microbial Transglutaminase.
    Spidel JL; Albone EF
    Methods Mol Biol; 2019; 2033():53-65. PubMed ID: 31332747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.